89.29
BATS BZX Real-Time Price
As of 2:57pm ET
 -0.33 / -0.37%
Today’s Change
84.25
Today|||52-Week Range
147.17
-14.44%
Year-to-Date
Novartis (NVS) Reports Encouraging Data on MS Candidate
12:01pm / Zacks.com - Paid Partner Content
Agios' Leukemia Drug Bodes Well for Growth & Strong Pipeline
Apr 18 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q1 Earnings: Is a Beat in the Cards?
11:06am / Zacks.com - Paid Partner Content
Alexion (ALXN) to Acquire Wilson Therapeutics for $855M
Apr 12 / Zacks.com - Paid Partner Content
Top Research Reports for IBM, McDonald's & Gilead
Apr 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close89.62
Today’s open89.50
Day’s range88.27 - 90.10
Volume204,228
Average volume (3 months)7,386,939
Market cap$69.6B
Data as of 2:57pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+46.18%
Earnings growth (this year)+13.81%
Earnings growth (next 5 years)+16.45%
Revenue growth (last year)+17.40%
P/E ratio24.6
Price/Sales6.58
Price/Book10.15

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.20+0.50%
BMYBristol-Myers Squibb-0.34-0.66%
NVONovo Nordisk-0.38-0.80%
ABBVAbbVie-0.35-0.38%
Data as of 2:57pm ET, 04/20/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)$1.95
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Executive VP, Chief Financial &
Accounting Officer
Peter N. Kellogg
Corporate headquarters
Summit, New Jersey

Forecasts